This long-term outcomes study is designed to collect safety and efficacy data on designated, commercially available, hip arthroplasty products.
Man or woman >18 years
Subjects with indication of arthroplasty surgery with Corin hip devices which are under assessment as part of this PMCF study
Subjects who agreed for study participation.
Subjects with existing tumour and/or particularly high surgical risk-
Subjects with anaesthetic risk class IV or higher
Subjects under guardianship and/or unable to follow procedures or matters related to the study (examples: Illiterate, recent psychotic or mania disorders and / or inability to comply with usual follow-up visits.)
Contraindications for arthroplasty with a Corin hip devices as per product IFU
Cohort of patients with a partial or total hip replacement (Corin implants)
Cohort
Prospective
Not listed
Evaluation of long-term outcome after hip arthroplasty with Corin implants.
Implants revision rate at 10-year FU hip arthroplasty
Evaluation of long-term outcome after hip arthroplasty with Corin implants at 15 and 20-year FU.
Implants revision rate at 15- and 20-year FU.
Evaluation of clinical performance of Corin hip implants
Change of Patient Reported Outcome Measures (PROMs)
Evaluation of Safety of Corin hip implants
Number, severity and causal relationship of procedure or implant-related Adverse Events
Radiological evaluation of positioning and osteointegration of Corin hip implants.
Number, thickness and location of radiolucent lines, osteolysis and heterotopic ossifications reported via radiological evaluation
